• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Oct31
Plus Therapeutics released FY2025 9 Months Earnings on October 30, 2025 (EST) with actual revenue of USD 3.846 M and EPS of USD -29.5631
03:00
Plus Therapeutics released FY2025 Q3 earnings on October 30 (EST), actual revenue USD 1.397 M (forecast USD 1.5 M), actual EPS USD -0.0411 (forecast USD -0.0275)
03:00
Sep25
UnitedHealth Insurance Reaches National Coverage Agreement with Plus Therapeutics for CNSide CSF Test
12:22
Aug15
Plus Therapeutics Meets NASDAQ Listing Rules and Receives Compliance Extension
13:49
Plus Therapeutics released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 2.449 M, actual EPS USD -0.5015
03:00
Plus Therapeutics released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 1.39 M (forecast USD 1.486 M), actual EPS USD -0.01 (forecast USD -0.09)
03:00

Schedules & Filings

Schedules
Filings
Oct30
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.397 M, Net Income -4.423 M, EPS -0.0411

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.39 M, Net Income 1.191 M, EPS -0.0065

May30
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.059 M, Net Income -13.44 M, EPS -29.5154

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
BBGI
16.690
+312.10%
+12.640
SRV.RT
0.0900
+111.76%
+0.048
BEAT
1.550
+92.43%
+0.745
ENVB
10.330
+74.49%
+4.410
BDRX
6.720
+65.11%
+2.650
ASPC
16.810
+60.40%
+6.330
IRBT
5.240
+48.44%
+1.710
CGTL
0.9727
+47.40%
+0.313
MIGI
6.700
+45.65%
+2.100
PLAB
37.350
+45.39%
+11.660
View More